BETAMETHASONE
Familial Amyotrophic Lateral Sclerosis
Edward KasaraskisEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Familial Amyotrophic Lateral Sclerosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Pyrimethamine Weill Medical College of Cornell University | Phase 1/2 | CCC |
ISIS-333611 Ionis Pharmaceuticals, Inc. | Phase 1 | CC |
Same molecule, other indications
BETAMETHASONE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →